Obese Placebo 1033
Homo sapiens
Liver tissue sample was collected from a morbidly obese patient (BMI ≥35 kg/m²) participating in the OCAGS clinical trial (ClinicalTrials.gov ID: NCT01625026), who received placebo treatment for 3 weeks prior to undergoing laparoscopic bariatric surgery. Patients included had no significant comorbidities or medications affecting metabolism. All samples were de-identified prior to molecular analysis. Ethical approval was granted by the appropriate Swedish authorities, and all participants provided informed consent.
ENA first public
2025-07-25
INSDC center name
Medical University Graz;MUG
INSDC status
public
SUBMISSION_TOOL
ena-upload-cli
SUBMISSION_TOOL_VERSION
0.8.0
Submitter Id
obese-placebo-1033
collection date
2015
common name
human
geographic location (country and/or sea)
Sweden
sample name
obese-placebo-1033
scientific_name
Homo sapiens